Pfizer, Biocon Brush Off Deal Talks As Speculative, But Is There Fire Behind The Smoke?

MUMBAI - Possibilities of a collaborative deal between Pfizer and Biocon have been dismissed as highly speculative by both companies for the last few weeks but going by the latest indications, the two could well be on course to joining forces for a few "significant projects.